Experimental leukemia combination proves toxic for older, frail patients
About 32 percent of older, sicker patients enrolled on a leukemia clinical trial experienced serious side effects from a treatment that combined a chemotherapy and an immunotherapy drug, leading investigators to pause the ...
Dec 10, 2019
0
4